Yazmin Odia | OMICS International

Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Yazmin Odia

Yazmin Odia, M.D., is the Director of Neuro-Oncology at Miami Cancer Institute, a part of Baptist Health South Florida.


Dr. Odia completed her medical training at the University of Chicago Pritzker School of Medicine, a Master of Science in Clinical Research at the Mayo Graduate School in Rochester, MN, and her neurology residency at the Johns Hopkins Hospitals. Prior to joining Columbia. She served as both clinical and research fellow in Neuro-Oncology and Neurology consultant at the National Institutes of Health (NIH) for three years.

Dr. Odia is certified in Neuro-Oncology through the United Council for Neurologic Subspecialties (UCNS). She also has clinical trial and translational research experience through various NIH-funded training grants. Her most recent work includes early phase clinical trials for patients with recurrent gliomas as well as translational research on clinical correlates of novel biomarkers in gliomas

Research Interest

Adult neurology and neuro-oncology